[Evaluation of the serum lysozyme level as a further parameter for predicting hematological tolerance in patients treated with cytostatic chemotherapy. Study of 134 cases].
作者信息
Neretto G, Agricola R, Giovanelli E, Poccardi G, Pellerito R, Furno F, Martinetto P, Pellegrino S, Daglio C, Tondolo M
出版信息
Recenti Prog Med. 1980 Oct;69(4):431-57.
PMID:7006015
Abstract
摘要
相似文献
1
2
[Lysozyme and cytostatic therapy].[溶菌酶与细胞抑制疗法]
Clin Ter. 1978 Dec 15;87(5):465-73.
3
Cancer chemotherapy.
Major Probl Intern Med. 1971;1:1-197.
4
The current status of cancer chemotherapy for selected human neoplasms.
Clin Ther. 1981;4(2):74-94.
5
Advanced cancer: New concepts of medical therapy.
Geriatrics. 1973 Nov;28(11):51-72.
6
[Results of clinical study of the antineoplastic antibiotic rubomycin].[抗肿瘤抗生素柔红霉素的临床研究结果]
Antibiotiki. 1968 Sep;13(9):846-50.
7
[Guidelines in the therapy of various neoplastic diseases with cytostatic drugs].
Praxis. 1969 Jun 3;58(22):703-7.
8
[Thoughts about the present state of tumour chemotherapy (author's transl)].关于肿瘤化疗现状的思考（作者译）
Arch Geschwulstforsch. 1976;46(3):225-9.
9
Investigations with 1,4-bis-(2'-mesyloxyethylamino)-1,4-dideoxy-meso-erythritol (R-74).
Neoplasma. 1971;18(3):277-82.
10
Serum lysozyme (muramidase) as functional test of granulopoiesis in the course of cytostatic therapy.血清溶菌酶（胞壁质酶）作为细胞抑制疗法过程中粒细胞生成的功能检测指标。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1974;101(6):935-41.
Zotero 插件